Dan Li

机构：Guiyang College of Traditional Chinese Medicine, Shanghai Jiao Tong University, Ruijin Hospital, Guizhou Cancer Hospital, State Key Laboratory of Oncogene and Related Genes · ORCID：0000-0003-4876-7879

发表论文 57 篇 · 总被引 874 次 · h-index 15

代表论文

• Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis (2024 · Acta Pharmaceutica Sinica B · 被引 59)
• Temporal enrichment of comammox Nitrospira and Ca. Nitrosocosmicus in a coastal plastisphere (2024 · The ISME Journal · 被引 14)
• LASS2 suppresses metastasis in multiple cancers by regulating the ferroptosis signalling pathway through interaction with TFRC (2024 · Cancer Cell International · 被引 11)
• Investigating the impact of STING pathway activation on breast cancer treatment outcomes: development and validation of a prognostic model (2024 · Frontiers in Immunology · 被引 6)
• Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer (2023 · Oncology Letters · 被引 5)
• A Prospective Investigator-Initiated Phase 1/2 Study of BCMA/CD19 Dual-Targeting CAR T Therapy in Patients with Relapsed/Refractory Multiple Myeloma Including Those with Extramedullary Disease (2024 · Blood · 被引 4)